Dow Jones

38 580,07

-0,02%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Sciclone Pharmaceuticals, Inc. (SCLN)
Sciclone Pharmaceuticals, Inc. (SCLN) Actualités

SCLN

Sciclone (SCLN)

Sciclone Pharmaceuticals, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SCLN

1 2 3 4 5 6 7 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/02/2018	15h13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
07/11/2017	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
31/10/2017	20h27	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
31/10/2017	20h24	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
25/10/2017	12h04	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
17/10/2017	22h07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
16/10/2017	23h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
13/10/2017	23h31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
13/10/2017	22h39	Edgar (US Regulatory)	(25-NSE)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
13/10/2017	22h24	PR Newswire (US)	Consortium Led By GL Capital Completes Acquisition Of SciClone	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
12/10/2017	00h07	PR Newswire (US)	NMI Holdings and Axcelis Technologies Set to Join S&P SmallCap 600	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
15/09/2017	22h33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
18/08/2017	23h20	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
17/08/2017	23h36	PR Newswire (US)	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
10/08/2017	22h05	PR Newswire (US)	SciClone Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
09/08/2017	22h20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
09/08/2017	22h05	PR Newswire (US)	SciClone Reports Second Quarter 2017 Financial Results	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
02/08/2017	22h05	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
27/07/2017	23h15	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
08/06/2017	12h00	PR Newswire (US)	SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
10/05/2017	22h12	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
10/05/2017	22h05	PR Newswire (US)	SciClone Reports First Quarter 2017 Financial Results	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
04/05/2017	12h00	PR Newswire (US)	SciClone Pharmaceuticals To Report First Quarter 2017 Financial Results On May 10, 2017	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
28/04/2017	22h24	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
27/03/2017	12h00	PR Newswire (US)	SciClone To Present At Needham Healthcare Conference On April 4, 2017	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
10/03/2017	20h21	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
09/03/2017	22h13	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
09/03/2017	22h02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
06/03/2017	12h00	PR Newswire (US)	SciClone Reports 2016 Financial Results And 2017 Outlook	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.
03/03/2017	22h05	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:SCLN	Sciclone Pharmaceuticals, Inc.